Publications by authors named "Sheila Asghar"

Claim this Profile
A
A Comprehensive Review of Neurologic Manifestations of COVID-19 and Management of Pre-existing Neurologic Disorders in Children.
Yunsung Kim, Sarah A Walser, Sheila J Asghar, Rohit Jain, Gayatra Mainali

J Child Neurol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal cord lesions in a pediatric patient with chronic kidney disease and review of literature: Questions.
Harmanpreet Tiwana, Himadri Patel, Sheila Asghar, Ashutosh Kumar, Michael Freeman

Pediatr Nephrol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal cord lesions in a pediatric patient with chronic kidney disease and review of literature: Answers.
Harmanpreet Tiwana, Himadri Patel, Sheila Asghar, Ashutosh Kumar, Michael Freeman

Pediatr Nephrol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNM1 Mutation in a child associated with progressive bilateral mesial temporal sclerosis.
Alexandra Lazzara, Sheila Asghar, Thomas Zacharia, Debra Byler

Clin Case Rep· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique presentation of rapidly fluctuating symptoms in a child with congenital myasthenic syndrome due to RAPSN mutation.
Ashutosh Kumar, Sheila Asghar, Robert Kavanagh, Matthew P Wicklund

Muscle Nerve· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variable manifestations of familial hemiplegic migraine associated with reversible cerebral edema in children.
Sheila J Asghar, Alessandra Milesi-Hallé, Chavvi Kaushik, Charles Glasier, Gregory B Sharp

Pediatr Neurol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproate attenuates dextroamphetamine-induced subjective changes more than lithium.
Morgan C Willson, Emily C Bell, Sanjay Dave, Sheila J Asghar, Brent M McGrath

Eur Neuropsychopharmacol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation.
Emily C Bell, Morgan C Willson, Alan H Wilman, Sanjay Dave, Sheila J Asghar

Hum Psychopharmacol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dextroamphetamine causes a change in regional brain activity in vivo during cognitive tasks: a functional magnetic resonance imaging study of blood oxygen level-dependent response.
Morgan C Willson, Alan H Wilman, Emily C Bell, Sheila J Asghar, Peter H Silverstone

Biol Psychiatry· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate.
Ren H Wu, Tina O'Donnell, Michele Ulrich, Sheila J Asghar, Christopher C Hanstock

Ann Gen Hosp Psychiatry· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients.
Peter H Silverstone, Sheila J Asghar, Tina O'Donnell, Michele Ulrich, Christopher C Hanstock

World J Biol Psychiatry· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers.
Sheila J Asghar, Veronique A M I Tanay, Glen B Baker, Andy Greenshaw, Peter H Silverstone

Hum Psychopharmacol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients.
Peter H Silverstone, Ren H Wu, Tina O'Donnell, Michele Ulrich, Sheila J Asghar

Int Clin Psychopharmacol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.
Michele L Ulrich, Susan Rotzinger, Sheila J Asghar, Paul Jurasz, Veronique A Tanay

J Psychiatry Neurosci· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dextro-amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study.
Peter H Silverstone, Tina O'Donnell, Michele Ulrich, Sheila Asghar, Christopher C Hanstock

Hum Psychopharmacol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
Peter H Silverstone, Ren H Wu, Tina O'Donnell, Michele Ulrich, Sheila J Asghar

Hum Psychopharmacol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis